In the preceding paper (Jacobson & Simpson, 1946) the fluorescence spectra of xanthopterin and leucopterin have been described. The fluorescence spectra of extracts of the mucous membrane of the stomach and intestine and of the argentaffine cells in these tissues were found to resemble, if not to be id6ntical with, that given by xanthopterin.
The present investigations were undertaken in an endeavour, first to identify the fluorescing material in tissue extracts, particularly liver extracts, which show antipernicious anaemia activity, and secondly to find whether there is any connexion between the intensity of the fluorescence and the haemopoietic activity. If the fluorescing substance could be iden-tified, and if the intensity of the fluorescence could be correlated with the therapeutic effect, then these results should throw some light on the chemical nature of the antipernicious anaemia factor, and should provide a method for estimating it quantitatively. Only complicated biological or clinical methods are at present available for determining the presence of the antipernicious anaemia factor .
METHODS
The same experimental technique as that described in the preceding,paper has been used. The first part of the problem requires the investigation of the position of the fluorescence bands of preparations showing haemopoietic activity, the second, the determination of the relative intensities of the light emitted by the different extracts. The following method was adopted. One substance is chosen as standard, and used at a concentration co. The fluorescence shown by this solution is photographed with a variety of exposure times. The fluorescence of any other material, at a concentration c in the same solvent, is similarly photographed. By comparing the two plates, it is possible to say that the blackening produced at a given characteristic wave-length by the standard, with an exposure of to sec., is equal to that given by the unknown, at the same wave-length, with an exposure of t sec.
If the cell used is the same, and the intensity of the incident light remains constant, then log1o (Io/I) =an log1o (tto0), where Io, I are the respective intensities of the fluorescent light emitted by the standard and the unknown solutions, at the wave-length under consideration, and n is the blackening coefficient of the plate.
If the specific intensity of the fluorescence p is proportional to the concentration of the solutions, then Io=poCo" I=pc, so that log1o (pocolpc) =n log10 (t/t0o) In order to make the results strictly comparable, the values of co, c should be expressed as molarities. If a convenient value of po is now chosen (say 10 or 100), the corresponding value of p may readily be calculated. In this connexion it should be noted that Koschara, Seipen & Aldred (1939) considered that the total intensity of fluorescence of preparations from urine was directly proportional to the amount of xanthopterin plus riboflavin present. Decker (1942) , however, found that the intensity of leucopterin fluorescence did not vary quite linearly with the concentration, particularly at dilutions of about 1: 1,000,000. As a first approximation, it should be sufficiently accurate to assume a linear relationship.
Accuracy
The absolute accuracy of the following results is not very great, but the order of magnitude is certainly correct. The apparatus used did not permit the exactly repeatable alinement of the cell, and the plates taken with the different materials were made over a period of nearly a year. The accuracy could be improved by taking the following precautions:
(1) the light source should be controlled so as to ensure that the emitted radiation should have a reasonably constant intensity over a considerable period;
(2) the cell should be more rigidly mounted, so that its aliuement with arc and slit is effectively unaltered after removal and replacsment; (3) the spectra of standard and unknown solutions should be photographed on the same plate, to avoid errors caused by the variation of the sensitivity of the plates, or in the time and temperature of development; (4) the value of n, the blackening factor, should be determined for each batch of plates used.
Even so, difficulties would be encountered in dealing with dark-coloured solutions, because then the intensity of fluorescence tends to fall off markedly across the cell, as the irradiating and fluorescent light is absorbed by the medium itself. If the solutions are highly diluted (50-250 times) in order to avoid this complication, then the exposure times have to be longer and the concentrations are so small that other errors are likely to be introduced.
In calculating the specific intensity of fluorescence, the molecular weights of the fluorescing materials were assumed to be the same. This generalization was necessary, because the true values were quite unknown. If the fluorescence of all these preparations is really due to one or other of the pterins, as is suggested by the spectroscopic evidence, then perhaps this assumption is not quite so unjustifiable as it at first appears. The concentrations were expressed in mg./ml.; the specific fluorescence intensity of the standard was conveniently chosen to be 10. The value of n the blackening factor for the panchromatic plates used varies between 0-8 and 1-0. Since the actual value of n employed merely alters the numerical values, and not the relative values of the specific intensities, a mean of 0-9 was chosen. It is important to realize that this method of calculation can only be used in a comparative way, and that if the different preparations are listed in order of their intensity of fluorescence, then this order is of more significance than the actual figures, which are only approximate.
RESULTS

Fluorescence spectra of ttssue extracts
In the course of this work eighteen commercial and experimental liver extracts have been examined, as well as extracts from a nodule of argentaffine cells (described in the previous paper), and from the mucous membrane of the stomach and small intestine, all of which are active against pernicious anaemia. The concentrated fractions T4, Fll, M3 and N of liver extract were very kindly supplied to us by Dr Neuberger of the National Institute of Medical Research, Hampstead. The commercial extracts are designated by I-IX: these numbers correspond to those used by . The fluorescence as observed directly seemed to be blue, although this was sometimes masked by the colour of the solutions when these were intensively pigmented by brown colouring matter. The substances investigated may be divided into two groups, nearly colourless preparations which are The nature of the fluorescent material (other than riboflavin) present in all these extracts should now be considered. In this connexion pyrimidine derivatives anc&aneurin (vitamin B1) which might possibly occur in the extracts, were spectroscopically examined. Alloxan, hypoxanthine, adenine and aneurin showed no fluorescence in neutral or alkaline solution. Uric acid and guanine gave weak bands near the mercury line at 4358 A. in alkaline solution only. None of these substances can therefore be responsible for the characteristic bands observed. The intensity distribution and position of the strong bands correspond most closely to those obtained with leucopterin but the spectrum might well be given by a mixture of leucopterin and some xanthopterin. Details of the fluorescence spectra of the other known pterins are not available except that of ichthyopterin, which can definitely be excluded.
On the whole from the above evidence, it seems ,possible that leucopterin or some closely related pterin is mainly responsible for the fluorescence. Leucopterin itself is insoluble in neutral or weak acid solution, but the emission from the extracts still appears under these conditions. This does not necessarily exclude leucopterin as the fluorescent material, as it might be present in colloidal suspension, or in combination with other molecules. If pure leucopterin is shaken with water, and the suspension is filtered, the resulting clear liquid still shows a marked fluorescence, which is only removed after prolonged centrifuging. Substances capable of protecting such a suspension, and rendering it stable over the range of pH used in these experiments, are likely to be present in the liver extracts examined.
Attempts to show that leucopterin or some similar pterin was present in combination, were not conclusive. The commercial extracts II and VI were heated with N-hydrochloric acid or N-sodium hydroxide at 600, i.e. under conditions which should have been favourable to hydrolysis. The chief result of this treatment was partial coagulation leading to increased background scattering, making the photographs very difficult to interpret. No definite change in intensity of fluorescence could be observed.
The presence of leucopterin, or a similar pterin, in liver extracts is interesting, as previously leucopterin itself has only been found in the wings of butterflies. That the same compound together with xanthopterin should also occur in extracts of the stomach and intestinal mucosa is of considerable significance, since both types of tissue extract have therapeutic activity against pernicious anaemia.
Haemopoietic activity of tissue extracts
Two methods are available for assessing the haemopoietic activity of liver, stomach and intestinal preparatioins, or of the pterins themselves; first the therapeutic action in cases of pernicious anaemia, and secondly the animal test . The results which have been obtained are shown in Table 1 ; not all the substances which have been examined spectroscopically were tested by both methods.
(1) Liver extracts
Liver extract T4 has been tested clinically elsewhere in 5 mg. dosage, which produced a good, but not maximum response; the same dose gave a maximum response in the animal test.
Liver extract Fll. This preparation gave a reticulocyte rise in a case of pernicious anaemia of from 0 5 to 14% on the fifth day after an intramuscular injection of 17 mg.; a rise of haemoglobin of from 55 to 76 %, and a rise of red blood cells of from 2-2 to 3-49 million/,ul. were observed 8 days after the injection. This represents a maximum response. A nearly maximum reticulocyte peak was produced by 5 mg. in the animal test.
Liver extract M3 was a fraction considerably less purified than T4 or F1. In a case of pernicious anaemia with 37 % haemoglobin and 1-41 million red cells/,l., 28 mg. given intramuscularly produced a rise in haemoglobin to 45 % and in red blood cells to 1-75 million/,ul. within 8 days after the injection, and the reticulocytes reached a peak of 10-2% on the fifth day. Thus Liver extract I. 2 ml. of this commercial extract, equivalent to 135 mg., produced on the fourth day a reticulocyte rise to 30.2% in a case of pernicious anaemia with 25% haemoglobin and 1-02 million red blood cells/pl., this represents a maximum response. In the animal test the same doser gave a maximum reticulocyte peak.
Liver extract II produced a maximum clinical response in a dose of 135 mg. Within 10 days after the intramuscular injection the haemoglobin rose from 48 to 63%, and the red cell count from 1.75 million to 2-64 million/pl., with areticulocyte peak of 21-8% on the sixth day after the injection. In a splenectomized rabbit this dose produced a maximum reticulocyte response.
Liver extract III. In a case of pernicious anaemia with an initial red cell count of 1-5 million cells/ld., 50'mg. produced a reticulocyte peak of 15.1% on the fifth day, which was less than a maximum response of 20-25 %. The same dose gave a submaximum response in the splenectomized rabbit. Liver extract IV. This extract is known to produce a satisfactory clinical response in doses of 400 mg. In a clinical case of pernicious anaemia with 1-82 million red cells/pl., 120 mg. failed to produce a rise in red cells and showed an insignifcant rise in reticulocytes of 3.5 % (maximum response -.20%). In the animal test 120 mg.
did not give a significant response.
Liver extract VI. This was a batch of extract I which for unknown reasons failed to produce a satisfactory clinical response in a dose of 135 mg. In the animal test 200 mg. of this extract produced a response which was comparable to that of 50-80 mg. of extract I.
A number of less concentrated liver extracts were also investigated; in these the antipernicious anaemia factor is present in such low concentrations that, for example, a 100 mg. dose of extract VII given intramuscularly to a case of pernicious anaemia with 1-62 million red cells/id. did not ahow any effect on the reticulocytes.
(2) Stomach and intestinal preparations
The antipernicious anaemia factor is elaborated in the mucous membranes of the stomach and intestine, being probably located in the scattered argentaffine cells. Its concentration must therefore be very low in stomach and intestinal preparations, so that clinical activity is only observed in cases of pernicious anaemia when doses of the I946 12 Vol. 40 PTERINS AND THE ANTIPERNICIOUS ANAEMIA FACTOR. II order of 10 g. dry matter daily are given for 10-14 days. Alcoholic fractionation of extracts prepared from the intestinal mucous membrane showed that the 70% ethanol soluble fraction was most active. In the animal test, doses of 6 mg. produced a submaximum response.
The relationship between intensity of fluorescence and haemopoietic activity The results of the calculations of the specific intensity of fluorescence are also shown in Table 1 . The standard chosen for this table was the preparation T4, which was colourless and had the highest specific intensity of fluorescence observed in these extracts. When the unknown preparation was not pigmented it was matched with the standard on both the characteristic bands, i.e. at 4650 and 5200 A. But when dealing with pigmented materials matching was confined to the 4650 A. band only, or alternatively the riboflavin fluorescence was suppressed by the addition of N-hydrochloric acid when both bands were usable. The results obtained by these two last methods agree within the experimental error. This procedure seems to work quite well for those materials which have considerable activity T4, F1L and M3, and for the best commercial extracts, for example II, III, IV and VII; but is less satisfactory for the weaker commercial preparations, and for the unfractionated extracts of the gastric and intestinal mucous membranes (which contain only a low concentration of active material). Possibly this is because the more highly active preparations are also the least pigmented, and so the results are less likely to be in error because of light absorption by the solution itself. Only a faint fluorescence was observed in some of the strongly pigmented commercial preparations, e.g. VIII, while some such as V, showed hardly any fluorescence unless they were considerably diluted (1: 50 or 1: 250) to minimize the interfering effect of the dark colouring matter.
In dealing with the dark brown liver extracts it was found useful to compare the relative intensities of their fluorescence by taking the spectra on one plate. For example, of three dark brown extracts to be analyzed, one contained 166 mg. dry matterjml. (extract IX), the two others each 40 mg./ml. (extract VIII). Dilutions were prepared as follows: extract IX 1: 250, i.e. 0-66 mg./ml. and the two batches of extract VIII 1 : 50, i.e. 0-8 mg./ml. The intensity of the fluorescence. spectrum of IX photographed with a 2 hr. exposure was very little fainter than that produced with a 5 hr. exposure of the two extracts VIII. As a 166 mg. dose of extract IX had a clinical activity corresponding to a 400 mg. dose of the two samples of VIII, the clinical and spectroscopic results were in good agreement.
Presence of faint fluorescence may thus be correlated with activity in large doses and there is no case where the clinical observations are in disagreement with the observed intensities.
For the purposes of comparison leucopterin is included in Table 1 . It is seen that leucopterin has considerable activity as measured by the animal test; xanthopterin also is active under these conditions. It is difficult to test the effect of leucopterin on patients suffering from pernicious anaemia directly as this pterin is nearly insoluble in suitable media; xanthopterin is not active in clinical cases. It is possible that leucopterin would also have no effect on cases of pernicious anaemia, as the pterin component is probably only part of the complex molecule which is the antipernicious anaemia factor. The animal can apparently utilize pterins as such to build up the haemopoietic factor but the human body is unable to do so. DISCUSSION
If the characteristic fluorescence bands of the tissue extracts, apart from that produced by riboflavin, arise from one substance only, an assumption which seems justifiable in view of the constant position of these bands and the absence of any definite background fluorescence, then the specific intensity of fluorescence should be proportional to the concentration of this particular material, at least to a first approximation. If the fluorescence is indeed produced by leucopterin itself as part of a complex, then the specific intensity of fluorescence for this compound is already known so that it is immediately possible to calculate its concentration in any of the preparations. The figures so obtained are given in Table 1 , expressed in percentage form. They represent an order of magnitude only, as the experimental conditions were not sufficiently rigidly controlled. In Table 1 the order of specific intensity of the characteristic fluorescence of the more potent preparations is compared with the haemopoietic activity as observed clinically and experimentally. In making this comparison, some latitude is necessary ininterpreting the data. The biological findings suffered from the defect that they could not all be obtained on one subject, nor were they the average ,of a large number of experiments, as only a few clinical cases were available for this purpose.
The important point to observe about the results is that the intensity of fluorescence and the haemopoietic activity of these preparations run parallel, greater intensity being associated with higher activity, and vice versa. This generalization would suggest that the fluorescence and the haemopoietic activity of the materials are due to the same substance-the antipernicious anaemia factor. Since the fluorescence can be attributed to leucopterin or to some closely related pterin with a similar spectrum, this would further imply that the antipernicious factor contains such a molecule in its structure, probably linked to at least one other group. In any v. Euler & Adler (1934) noticed that an ethanol extract of the combined retina and choroid from certain fishes fluoresced a brilliant blue. At that time they were principally interested in the distribution and function of free riboflavin in fish retinas and considered that the blue-fluorescent material was related to riboflavin though they did not decide whether it occurred naturally or was a breakdown product formed during extraction. They found that, unlike lumichrome, the blue fluorescing substance formed by irradiation of riboflavin in weak alkali, the material from fish eyes was not soluble in chloroform. Otherworkers have described blue-fluorescent extracts obtainable from the eyes and from the skins of fish and other animals. Table 1 gives a list of those animals which have such fluorescent substances in their eyes. Gourevitch (1938 a, b) , working with the eyes of the carp OyprinUa carpio, studied the effect of change of pH and of oxidizing and reducing 
